Randhawa Simrat bought DNTH
September 1, 2026 · Form 4 insider transaction
Randhawa Simrat bought 9,375 shares of Dianthus Therapeutics, Inc. at $22.07 per share, a transaction worth $206.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
9,375
Price
$22.07
Total value
$206.9K
InsiderRandhawa Simrat
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 1, 2026
Filing dateSeptember 3, 2026
Shares owned after27,124
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025.